The Role of the Incretin Hormones GIP and GLP-1 in the Pathogenesis of Type 2 Diabetes

被引：0

作者：

Meier, J. J. ^{[1
]}

机构：

[1] Klinikum Ruhr Univ Bochum, St Josef Hosp, Med Klin 1, D-44791 Bochum, Germany

来源：

DIABETOLOGIE UND STOFFWECHSEL | 2009年 / 4卷 / 05期

关键词：

GASTRIC-INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; 1ST-DEGREE RELATIVES; ORAL GLUCOSE; RECEPTOR EXPRESSION; 7-36; AMIDE; SECRETION; PLASMA; HYPERGLYCEMIA;

D O I：

10.1055/s-0029-1224610

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The incretin effect, i.e. the postprandial augmentation of insulin secretion by gastrointestinal hormones, mediates similar to 50-70% of the meal-related increments in insulin secretion in healthy individuals. In contrast, the incretin effect is almost completely absent in patients with type 2 diabetes. The impaired incretin effect in type 2 diabetes has been mainly attributed to the reduced insulinotropic activity of GIP, whereas the actions of GLP-1 are largely preserved. Furthermore, a diminished secretion of GLP-1 has been suggested to contribute to the impaired incretin effect in type 2 diabetes, but this finding has not been confirmed in the majority of studies. This article aims to compare the secretion and action of the incretins GIP and GLP-1 between patients with type 2 diabetes and healthy individuals. In addition, the importance of alterations in the entero-insular axis for the pathogenesis of type 2 diabetes will be discussed.

引用

页码：295 / 300

页数：6

共 50 条

[1] On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus
Vilsboll, T
[J]. DANISH MEDICAL BULLETIN, 2004, 51 (04) : 364 - 370
[2] INCRETIN HORMONES GIP AND GLP-1
Kieffer, Timothy James
Fujita, Yukihiro
Riedel, Michael
Wideman, Rhonda
[J]. JOURNAL OF PHYSIOLOGICAL SCIENCES, 2009, 59 : 87 - 87
[3] Immunoassays for the incretin hormones GIP and GLP-1
Deacon, Carolyn F.
Holst, Jens J.
[J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) : 425 - 432
[4] GIP and GLP-1, the two incretin hormones: Similarities and differences
Seino, Yutaka
Fukushima, Mitsuo
Yabe, Daisuke
[J]. JOURNAL OF DIABETES INVESTIGATION, 2010, 1 (1-2): : 8 - 23
[5] Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes
Nauck, MA
El-Ouaghlidi, A
Gabrys, B
Hücking, K
Holst, JJ
Deacon, CF
Gallwitz, B
Schmidt, WE
Meier, JJ
[J]. REGULATORY PEPTIDES, 2004, 122 (03) : 209 - 217
[6] The incretin system in healthy humans: The role of GIP and GLP-1
Hoist, Jens Juul
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 96 : 46 - 55
[7] Mechanisms underlying the rapid degradation and elimination of the incretin hormones GLP-1 and GIP
Mentlein, Rolf
[J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (04) : 443 - 452
[8] GIP and GLP-1 as incretin hormones: Lessons from single and double incretin receptor knockout mice
Hansotia, T
Drucker, DJ
[J]. REGULATORY PEPTIDES, 2005, 128 (02) : 125 - 134
[9] The incretin hormones GIP and GLP-1 in diabetic rats: Effects on motility and insulin secretion
Edholm, T
Cejvan, K
Efendic, S
Schmidt, PT
Hellstrom, PM
[J]. GASTROENTEROLOGY, 2004, 126 (04) : A144 - A144
[10] The incretin hormones GLP-1 and GIP are partly colocalized in the cut in man, pig and rat
Mortensen, K
Petersen, LL
Orskov, C
Holst, JJ
[J]. DIABETES, 2001, 50 : A310 - A311

← 1 2 3 4 5 →